Oligomers of the ATPase EHD2 confine caveolae to the plasma membrane through association with actin, EMBO J, vol.31, pp.2350-2364, 2012. ,
EHD2 regulates caveolar dynamics via ATP-driven targeting and oligomerization, Mol. Biol. Cell, vol.23, pp.1316-1329, 2012. ,
EHD2 is a mechanotransducer connecting caveolae dynamics with gene transcription, J Cell Biol, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-02426440
Effects of EHD2 interference on migration of esophageal squamous cell carcinoma, Med. Oncol, vol.30, 2013. ,
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy, Gynecol. Oncol, vol.103, pp.405-416, 2006. ,
Correlation of histopathologic characteristics to protein expression and function in malignant melanoma, PLoS One, vol.12, 2017. ,
Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma, Dig. Dis. Sci, vol.61, pp.2554-2567, 2016. ,
Role of EHD2 in migration and invasion of human breast cancer cells, Tumour Biol, vol.36, pp.3717-3726, 2015. ,
Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin, J. Mol. Histol, vol.46, pp.221-231, 2015. ,
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin, vol.68, pp.394-424, 2018. ,
Molecular portraits of human breast tumours, Nature, vol.406, pp.747-752, 2000. ,
Triple-negative breast cancer, N. Engl. J. Med, vol.363, 1938. ,
URL : https://hal.archives-ouvertes.fr/hal-02463255
, Breast cancer. Lancet, vol.389, issue.16, pp.31891-31899, 2017.
Molecular profiling in breast cancer, Rev. Endocr. Metab. Disord, vol.8, pp.185-198, 2007. ,
Metaplastic Breast Carcinoma Versus Triple-Negative Breast Cancer: Survival and Response to Treatment, Medicine, vol.94, 2015. ,
Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease, Nat. Rev. Clin. Oncol, vol.13, pp.674-690, 2016. ,
Rationale and Means to Target Pro-Inflammatory Interleukin-8 (CXCL8) Signaling in Cancer, Pharmaceuticals, vol.6, pp.929-959, 2013. ,
Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells, Breast Cancer Res, vol.15, 2013. ,
Differential roles of C-terminal Eps15 homology domain proteins as vesiculators and tubulators of recycling endosomes, J. Biol. Chem, vol.288, pp.30172-30180, 2013. ,
The caveolae dress code: structure and signaling, Curr. Opin. Cell Biol, vol.47, pp.117-125, 2017. ,
EHD Proteins Cooperate to Generate Caveolar Clusters and to Maintain Caveolae during Repeated Mechanical Stress, Curr. Biol, vol.27, pp.2951-2962, 2017. ,
Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer, Cancer Res, vol.60, pp.2290-2299, 2000. ,
Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice, Br. J. Cancer, vol.81, pp.647-653, 1999. ,
Depletion of intrinsic expression of Interleukin-8 in prostate cancer cells causes cell cycle arrest, spontaneous apoptosis and increases the efficacy of chemotherapeutic drugs, Mol. Cancer, vol.8, 2009. ,
Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases, Theranostics, vol.7, pp.1543-1588, 2017. ,
Prognostic implication of histological features associated with EHD2 expression in papillary thyroid carcinoma, PLoS One, vol.12, 2017. ,
Caveolae and cancer: A new mechanical perspective, Biomed. J, vol.38, pp.367-379, 2015. ,
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, J. Clin. Invest, vol.121, pp.2750-2767, 2011. ,
Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective study, Breast Cancer Res. Treat, vol.43, pp.7-14, 1997. ,
Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer, J. Clin. Oncol, vol.31, pp.203-209, 2013. ,
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer, J. Clin. Oncol, vol.25, pp.118-145, 2007. ,
HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?, Br. J. Cancer, vol.96, pp.654-659, 2007. ,
Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer, Oncogene, vol.20, pp.8109-8115, 2001. ,
Revision of the standards for the assessment of hormone receptors in human breast cancer; report of the second E, Eur J. Cancer, vol.16, pp.1513-1515, 1979. ,
An antigen immunologically related to the external domain of gp185 is shed from nude mouse tumors overexpressing the c-erbB-2 (HER-2/neu) oncogene, Cancer Res, vol.51, pp.2593-2598, 1991. ,
Real-time reverse transcription-PCR assay for future management of ERBB2-based clinical applications, Clin. Chem, vol.45, pp.1148-1156, 1999. ,
Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value, Mol. Cancer Res, vol.14, pp.623-633, 2016. ,
The meaning and use of the area under a receiver operating characteristic (ROC) curve, Radiology, vol.143, pp.29-36, 1982. ,